The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Santec Holdings Corp
F:8AU
|
JP |
|
OVS SpA
MIL:OVS
|
IT |
|
G
|
Geiger Energy Corp
XTSX:BEEP
|
CA |
|
ANTA Sports Products Ltd
F:AS7
|
CN |
|
H
|
Hormel Foods Corp
XMUN:HO7
|
US |
|
S
|
Swiss Prime Site AG
XMUN:SU1N
|
CH |
|
Evogene Ltd
NASDAQ:EVGN
|
IL |
|
NovaBridge Biosciences
F:0VY
|
US |
|
GlobeStar Therapeutics Corp
OTC:GSTC
|
US |
|
O
|
Old National Bancorp
F:ON1
|
US |
|
M
|
Mon Courtier Energie SAS
PAR:ALMCE
|
FR |
|
G
|
Givaudan SA
XMUN:GIN
|
CH |
|
Molinos Rio de la Plata SA
OTC:MOPLF
|
AR |
|
Meko AB
F:1OM
|
SE |
|
P
|
Poly Property Group Co Ltd
F:CMJ
|
HK |
|
Mizuno Corp
F:MIZ
|
JP |
|
F
|
Forcs Co Ltd
KOSDAQ:189690
|
KR |
|
Davictus PLC
LSE:DVT
|
MY |
|
R
|
Rigolleau SA
BCBA:RIGO
|
AR |
|
WisdomTree Inc
F:1WT
|
US |
|
La Francaise de l Energie SA
F:LFX
|
FR |
|
Shufersal Ltd
OTC:SHUFF
|
IL |
|
Promotora de Informaciones SA
MAD:PRS
|
ES |
|
T
|
Tocvan Ventures Corp
CNSX:TOC
|
CA |
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
8AU does not have any price targets made by Wall Street professionals.
Over the last 13 years, the compound annual growth rate for Revenue has been 22%. The projected CAGR for the next 3 years is 19%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 40%. The projected CAGR for the next 3 years is 19%.
Over the last 13 years, the compound annual growth rate for Net Income has been 38%. The projected CAGR for the next 3 years is 20%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more